Home/Filings/4/0000950170-25-113800
4//SEC Filing

McAvoy David R. 4

Accession 0000950170-25-113800

CIK 0000818686other

Filed

Sep 8, 8:00 PM ET

Accepted

Sep 9, 4:02 PM ET

Size

4.8 KB

Accession

0000950170-25-113800

Insider Transaction Report

Form 4
Period: 2025-09-05
McAvoy David R.
EVP, Chief Legal Officer
Transactions
  • Purchase

    Ordinary Shares

    2025-09-05$18.86/sh+1,113$20,98813,027 total
Footnotes (1)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Documents

1 file

Issuer

TEVA PHARMACEUTICAL INDUSTRIES LTD

CIK 0000818686

Entity typeother

Related Parties

1
  • filerCIK 0001758842

Filing Metadata

Form type
4
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 4:02 PM ET
Size
4.8 KB